Novel therapeutic strategies using hypomethylating agents in the treatment of myelodysplastic syndrome

By Ishikawa Takayuki  

International Journal of Clinical Oncology, Vol. 19, Iss. 1, 2014-02 ,pp. : 10-15

Springer Publishing Company

Access to resources Recommend Favorite

Myelodysplastic Syndrome: Etiology, Prognosis and Management

By Neumeister P.  

American Journal of Cancer, Vol. 1, Iss. 5, 2002-01 ,pp. : 301-311

Adis International

Access to resources Recommend Favorite

The cell growth, morphology and immunocytochemistry of novel cell line established from a bone marrow of the patient with therapy-related myelodysplastic syndrome, entitled PC-MDS

By Bogdanović Gordana   Jakimov Dimitar   Stojiljkovic Bratislav   Jurišić Vladimir  

Medical Oncology, Vol. 24, Iss. 4, 2007-12 ,pp. : 419-424

Humana Press, Inc

Access to resources Recommend Favorite

Myelofibrosis in primary myelodysplastic syndromes: Clinical and Biological Significance

By Marisavljević D.   Rolović Z.   Ćemerikić V.   Bošković D.   Ćolović M.  

Medical Oncology, Vol. 21, Iss. 4, 2004-12 ,pp. : 325-331

Humana Press, Inc

Access to resources Recommend Favorite

Hypocellular myelodysplastic syndromes: Clinical and biological significance

By Marisavljević Dragomir   Čemerikić Vesna   Rolović Zoran   Bošković Darinka   Čolović Milica  

Medical Oncology, Vol. 22, Iss. 2, 2005-06 ,pp. : 169-175

Humana Press, Inc

Access to resources Recommend Favorite